Skip to main content
. 2019 Sep 23;11(Suppl 1):29–36. doi: 10.1159/000501990

Fig. 2.

Fig. 2

Patient No. 2, at presentation (a), after 3 months (b), and 6 months (c) of secukinumab treatment.